Literature DB >> 6871844

Direct suppression of natural killer activity in human peripheral blood leukocyte cultures by glucocorticoids and its modulation by interferon.

N J Holbrook, W I Cox, H C Horner.   

Abstract

In vitro treatment of human peripheral blood leukocytes for 18 to 24 hr with physiological concentrations of glucocorticoids resulted in a marked decrease (up to 90%) in natural killer (NK) activity. The effect on NK activity was both dose and time dependent and was specific for glucocorticoids. Glucocorticoids had no effect when added directly to the 4-hr 51Cr release cytotoxicity assay, nor did they alter the susceptibility of K562 cells to NK-mediated cytolysis. Glucocorticoid-induced inhibition occurred in Percoll-fractionated peripheral blood leukocytes enriched for NK activity. Viabilities of steroid-treated and untreated cultures were similar. Mixing experiments failed to demonstrate the involvement of suppressor activity in the inhibition. Purified cloned human leukocyte interferon subtype A and inducers of interferon enhanced NK activity in the presence of glucocorticoid, although the levels of enhancement were lower than those produced by these agents in the absence of the steroid. Thus, glucocorticoids appear to suppress human NK activity by interacting directly with the NK effector cell, and our results obtained with physiological concentrations of these steroids suggest that they may play an important role in regulating NK activity in vivo. Additionally, these findings suggest a possible means for overriding this immunosuppressive side effect of glucocorticoid therapy by simultaneous treatment with interferon.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6871844

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

1.  Vitamin D, thyroid hormones and muscle mass influence natural killer (NK) innate immunity in healthy nonagenarians and centenarians.

Authors:  E Mariani; G Ravaglia; P Forti; A Meneghetti; A Tarozzi; F Maioli; F Boschi; L Pratelli; A Pizzoferrato; F Piras; A Facchini
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

Review 2.  Biobehavioral factors and cancer progression: physiological pathways and mechanisms.

Authors:  Susan K Lutgendorf; Anil K Sood
Journal:  Psychosom Med       Date:  2011-10-21       Impact factor: 4.312

3.  Cortisol and immune interferon can interact in the modulation of human natural killer cell activity.

Authors:  R Cavallo; M L Sartori; G Gatti; A Angeli
Journal:  Experientia       Date:  1986-02-15

4.  Human NK Cell Cytoskeletal Dynamics and Cytotoxicity Are Regulated by LIM Kinase.

Authors:  Melody G Duvall; Mary E Fuhlbrigge; Roisin B Reilly; Katherine H Walker; Ayşe Kılıç; Bruce D Levy
Journal:  J Immunol       Date:  2020-07-08       Impact factor: 5.422

Review 5.  Need for immunologic stimulators during immunosuppression produced by major cancer surgery.

Authors:  W H Cole; L Humphrey
Journal:  Ann Surg       Date:  1985-07       Impact factor: 12.969

6.  In vivo suppression of NK cell cytotoxicity by stress and surgery: glucocorticoids have a minor role compared to catecholamines and prostaglandins.

Authors:  Ella Rosenne; Liat Sorski; Lee Shaashua; Elad Neeman; Pini Matzner; Ben Levi; Shamgar Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2013-12-12       Impact factor: 7.217

7.  Glucocorticoid dysregulation of natural killer cell function through epigenetic modification.

Authors:  Karen Krukowski; Justin Eddy; Kelly Loster Kosik; Teresa Konley; Linda Witek Janusek; Herbert L Mathews
Journal:  Brain Behav Immun       Date:  2010-07-23       Impact factor: 7.217

8.  Glucocorticoid receptor mediated suppression of natural killer cell activity: identification of associated deacetylase and corepressor molecules.

Authors:  Kristin A Bush; Karen Krukowski; Justin L Eddy; Linda Witek Janusek; Herbert L Mathews
Journal:  Cell Immunol       Date:  2012-03-21       Impact factor: 4.868

9.  Corticosteroids inhibit the generation of lymphokine-activated killer activity in vitro.

Authors:  D W McVicar; R E Merchant; L H Merchant; H F Young
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

10.  Suppression of natural killer-cell function in humans following thermal and traumatic injury.

Authors:  B A Blazar; M L Rodrick; J B O'Mahony; J J Wood; P Q Bessey; D W Wilmore; J A Mannick
Journal:  J Clin Immunol       Date:  1986-01       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.